Evolution of Devices in Diabetes Management

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Diabetes Technology & Therapeutics

• Publication date

  2011-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/dia.2011.0058PMID 21668342
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Closing the loop

  2012cited by this paper
• Insulin-pump therapy for type 1 diabetes mellitus.

  2012cited by this paper
• Continuous glucose monitoring: coming of age?

  2012cited by this paper
• Contracting and Monitoring Relationships for Adolescents with Type 1 Diabetes: A Pilot Study

  2011cited by this paper
• The Diabeo Software Enabling Individualized Insulin Dose Adjustments CombinedWith Telemedicine Support Improves HbA 1 c in Poorly Controlled Type 1 Diabetic Patients A 6-month , randomized , open-label , parallel-group , multicenter trial ( TeleDiab 1 Study )

  2011influential reference
• Performance of a New Reusable Insulin Pen

  2011cited by this paper
• Use of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes on Multiple Daily Injections Versus Continuous Subcutaneous Insulin Infusion Therapy

  2011cited by this paper
• The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA1c in Poorly Controlled Type 1 Diabetic Patients

  2011cited by this paper
• Qualitative Evaluation of a Mobile Phone and Web-Based Collaborative Care Intervention for Patients with Type 2 Diabetes

  2011influential reference
• Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial.

  2010influential reference
• A Review of Insulin Pen Devices

  2010cited by this paper
• Health-Related Quality of Life, Treatment Satisfaction, and Costs Associated With Intraperitoneal Versus Subcutaneous Insulin Administration in Type 1 Diabetes

  2010cited by this paper
• Executive Summary: Standards of Medical Care in Diabetes—2010

  2010cited by this paper
• Practical Aspects of Insulin Pen Devices

  2010cited by this paper
• Continuous glucose monitoring--coming of age.

  2010cited by this paper
• Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

  2010cited by this paper
• Prevention of Nocturnal Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension

  2010cited by this paper
• Therapeutics of Diabetes Mellitus: Focus on Insulin Analogues and Insulin Pumps

  2010influential reference
• Accuracy of a New Real-Time Continuous Glucose Monitoring Algorithm

  2010cited by this paper
• Attempt to improve glucose control in type 2 diabetic patients by education about real-time glucose monitoring.

  2010cited by this paper
• Comparison of a Multiple Daily Insulin Injection Regime (Basal Once-Daily Glargine plus Mealtime Lispro) and CSII (Lispro) in Type 1 Diabetes: a Randomized Open Parallel Multicenter Study

  2009cited by this paper
• Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005).

  2009cited by this paper
• Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1 Diabetes

  2009cited by this paper
• What is artificial endocrine pancreas? Mechanism and history.

  2009cited by this paper
• Real-life application and validation of flexible intensive insulin-therapy algorithms in type 1 diabetes patients.

  2009cited by this paper
• Comparative Device Assessments

  2009cited by this paper
• Investigation of quality of life and family burden issues during insulin pump therapy in children with Type 1 diabetes mellitus—a large‐scale multicentre pilot study 1

  2009cited by this paper
• Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy

  2009influential reference
• Insulin therapy: Question this issue

  2009cited by this paper
• Improved Glycemic Control through Continuous Glucose Sensor-Augmented Insulin Pump Therapy: Prospective Results from a Community and Academic Practice Patient Registry

  2009cited by this paper
• Artificial pancreas: an emerging approach to treat Type 1 diabetes

  2009cited by this paper
• Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial

  2009cited by this paper
• Continuous postoperative blood glucose monitoring and control by artificial pancreas in patients having pancreatic resection: a prospective randomized clinical trial.

  2009cited by this paper
• Accuracy of the SEVEN® Continuous Glucose Monitoring System: Comparison with Frequently Sampled Venous Glucose Measurements

  2009cited by this paper
• American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.

  2009cited by this paper
• Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes

  2009cited by this paper
• Preventing Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension

  2009cited by this paper
• Glucose sensors: a review of current and emerging technology

  2009cited by this paper
• Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes

  2009influential reference
• A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion

  2009cited by this paper
• Clinical review: Realistic expectations and practical use of continuous glucose monitoring for the endocrinologist.

  2009influential reference
• Insulin pump therapy: guidelines for successful outcomes.

  2009influential reference
• Comparison of the Numerical and Clinical Accuracy of Four Continuous Glucose Monitors

  2008cited by this paper
• Continuous glucose monitoring and intensive treatment of type 1 diabetes.

  2008cited by this paper
• Insulin Delivery Route for the Artificial Pancreas: Subcutaneous, Intraperitoneal, or Intravenous? Pros and Cons

  2008influential reference
• Improved Glycemic Control in Intensively Treated Adult Subjects with Type 1 Diabetes Using Insulin Guidance Software

  2008influential reference
• Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus

  2008cited by this paper
• Dose Accuracy Comparison Between SoloSTAR and FlexPen at Three Different Dose Levels

  2008cited by this paper
• The future of continuous glucose monitoring: closed loop.

  2008cited by this paper
• Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas

  2008cited by this paper
• Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta‐analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion

  2008cited by this paper
• Clinical experience with an implanted closed-loop insulin delivery system.

  2008influential reference
• Diabetes care - insulin delivery in a changing world.

  2008cited by this paper
• Effects of insulin pump vs. injection treatment on quality of life and impact of disease in children with type 1 diabetes mellitus in a randomized, prospective comparison

  2008cited by this paper
• Comparison of Continuous Blood Glucose Measurement with Conventional Documentation of Hypoglycemia in Patients with Type 2 Diabetes on Multiple Daily Insulin Injection Therapy

  2007cited by this paper
• A new approach to diabetic control: fuzzy logic and insulin pump technology.

  2007cited by this paper
• Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.

  2007cited by this paper
• Real-time continuous glucose monitoring

  2007cited by this paper
• A pilot trial in pediatrics with the sensor-augmented pump: combining real-time continuous glucose monitoring with the insulin pump.

  2007cited by this paper
• Accuracy of the 5-Day FreeStyle Navigator Continuous Glucose Monitoring System

  2007cited by this paper
• Implantable insulin pumps. A position statement about their clinical use.

  2007cited by this paper
• Health Outcomes and Economic Impact of Therapy Conversion to a Biphasic Insulin Analog Pen Among Privately Insured Patients with Type 2 Diabetes Mellitus

  2007cited by this paper
• Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH‐based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5‐nations trial

  2006cited by this paper
• Insulin pump therapy in type 1 diabetes mellitus.

  2006cited by this paper
• Continuous glucose monitoring and closed‐loop systems

  2006cited by this paper
• An overview on the development of a bio‐artificial pancreas as a treatment of insulin‐dependent diabetes mellitus

  2006cited by this paper
• Metabolic modelling and the closed-loop insulin delivery problem.

  2006cited by this paper
• Hypoglycemia and ketoacidosis with insulin pump therapy in children and adolescents

  2006cited by this paper
• OmniPod Insulin Management System

  2006cited by this paper
• Bomba de infusão de insulina em diabetes melito tipo 1

  2006cited by this paper
• Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c.

  2004cited by this paper
• Insulin pump therapy: a meta-analysis.

  2003cited by this paper
• Performance assessment of the Medtronic‐MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in Type 1 diabetic subjects

  2003cited by this paper
• Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials

  2002cited by this paper
• Increased responses of glucagon and glucose production to hypoglycemia with intraperitoneal versus subcutaneous insulin treatment.

  2000influential reference
• Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring.

  1999cited by this paper
• Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring.

  1999cited by this paper
• Local Adverse Events Associated With Long-Term Treatment by Implantable Insulin Pumps: The French EVADIAC Study Group experience

  1998cited by this paper
• Decreased Severe Hypoglycemia Frequency During Intraperitoneal Insulin Infusion Using Programmable Implantame Pumps

  1996cited by this paper
• Decreased severe hypoglycemia frequency during intraperitoneal insulin infusion using programmable implantable pumps. Evadiac Study Group.

  1996cited by this paper
• Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.

  1996cited by this paper
• Development of a Miniaturized Glucose Monitoring System by Combining a Needle-Type Glucose Sensor With Microdialysis Sampling Method: Long-term subcutaneous tissue glucose monitoring in ambulatory diabetic patients

  1994cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Peritoneal and subcutaneous absorption of insulin in type I diabetic subjects.

  1993cited by this paper
• Variation of insulin absorption during subcutaneous and peritoneal infusion in insulin-dependent diabetic patients with unsatisfactory long-term glycaemic response to continuous subcutaneous insulin infusion.

  1991cited by this paper
• Free-Insulin Profiles After Intraperitoneal, Intramuscular, and Subcutaneous Insulin Administration

  1986cited by this paper
• The development of an artificial beta cell system and its validation in depancreatized dogs: the physiological restoration of blood glucose homeostasis.

  1979cited by this paper
• Evaluation of exogenous insulin homoeostasis by the artificial pancreas in insulin-dependent diabetes

  1977cited by this paper
• The development of Biostator, a Glucose Controlled Insulin Infusion System (GCIIS).

  1977cited by this paper
• The Artificial Beta Cell - A Continuous Control of Blood Sugar by External Regulation of Insulin Infusion (Glucose Controlled Insulin Infusion System)

  1974cited by this paper
• Clinical Control of Diabetes by the Artificial Pancreas

  1974cited by this paper
• The artificial beta cell--a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system).

  1974cited by this paper

• “Obviously, Nothing’s Gonna Happen in Five Minutes”: How Adolescents and Young Adults Infrastructure Resources to Learn Type 1 Diabetes Management

  2024influential citation
• Advancements in Insulin Pumps: A Comprehensive Exploration of Insulin Pump Systems, Technologies, and Future Directions

  2024cites this paper
• Using Diabetes Technology in Hospitalized Patients.

  2024cites this paper
• Non-Invasive Delivery of Insulin for Breaching Hindrances against Diabetes.

  2024cites this paper
• Structure and properties of insulin

  2022cites this paper
• A review of reusable insulin pens and features of TouStar—a new reusable pen with a dedicated cartridge

  2021cites this paper
• Delivery of Insulin via Skin Route for the Management of Diabetes Mellitus: Approaches for Breaching the Obstacles

  2021cites this paper
• Wireless and battery-free platforms for collection of biosignals.

  2021cites this paper
• A fully implantable device for diffuse insulin delivery at extraperitoneal site for physiological treatment of type 1 diabetes.

  2020cites this paper
• RECENT ADVANCED INSULIN DELIVERY METHOD FOR FUTURE *

  2020cites this paper
• Recent advances and near future of insulin production and therapy.

  2019cites this paper
• Proactive diabetes management: research directions

  2019cites this paper
• Control of Complex Biological Systems Utilizing the Neural Network Predictor

  2019cites this paper
• Amperometric enzyme-based biosensors: refined bioanalytical tools for in vivo biomonitoring

  2018cites this paper
• Amperometric enzyme-based biosensors : refined bioanalytical tools for in vivo biomonitoring

  2018cites this paper
• Closed loop control of blood glucose level with neural network predictor for diabetic patients

  2017cites this paper
• Laboratory medicine and mobile health technologies at crossroads: Perspectives for the management of chronic diseases

  2016cites this paper
• Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices

  2016cites this paper
• The Clinical Accuracy of Non-Invasive Glucose Monitoring for ex vivo Artificial Pancreas

  2016cites this paper
• Minimally Invasive Pseudo-continuous Blood Glucose Monitoring: Results from In-Vitro and In-Vivo Testing of the eTac

  2016cites this paper
• Insulin delivery methods: Past, present and future

  2016influential citation
• Minimally invasive pseudo-continuous blood glucose monitoring: Results from in-vitro and in-vivo testing of the e-Mosquito

  2016cites this paper
• Numerical and clinical precision of continuous glucose monitoring in Colombian patients treated with insulin infusion pump with automated suspension in hypoglycemia.

  2015influential citation
• Precisión numérica y clínica de la monitorización continua de glucosa en pacientes colombianos en terapia con bomba de infusión de insulina con suspensión automática en hipoglucemia

  2015cites this paper
• Numerical and clinical precision of continuous glucose monitoring in Colombian patients treated with insulin infusion pump with automated suspension in hypoglycemia

  2015cites this paper
• Accuracy and user performance evaluation of the Contour(®) Next Link 2.4 blood glucose monitoring system.

  2015cites this paper
• Durability of the Continuous Subcutaneous Insulin Infusion (CSII) Patch Adhesive

  2015influential citation
• A ADMINISTRAÇÃO SISTÊMICA E TÓPICA DE VITAMINAS ANTIOXIDANTES ACELERA A CICATRIZAÇÃO DE FERIDAS CUTÂNEAS EM CAMUNDONGOS DIABÉTICOS

  2014cites this paper
• Systematic review: continuous intraperitoneal insulin infusion with implantable insulin pumps for diabetes mellitus

  2014cites this paper
• Testing versus guessing blood glucose values: impact on self-care behaviors in type 2 diabetes

  2014cites this paper
• A Relational Fairness Perspective on Individuality and Individualization in Contemporary Approaches to Compensation in Organizations

  2014cites this paper
• Original article Testing versus guessing blood glucose values: impact on self-care behaviors in type 2 diabetes

  2014cites this paper
• Effects of Eight Weeks of High-intensity Interval Training on Blood Glucose Regulation, Endothelial Function, and Visceral Fat in Obese Adults

  2013cites this paper
• An Online Failure Detection Method of the Glucose Sensor-Insulin Pump System: Improved Overnight Safety of Type-1 Diabetic Subjects

  2013cites this paper
• A Multistep Algorithm for Processing and Calibration of Microdialysis Continuous Glucose Monitoring Data

  2013influential citation
• Development of Wearable Semi-invasive Blood Sampling Devices for Continuous Glucose Monitoring: A Survey

  2013influential citation
• The need for better insulin therapy

  2013cites this paper
• Continuous health monitoring: integrating biomarkers for the management of chronic diseases

  2012cites this paper
• Restoring insulin production for type 1 diabetes

  2012cites this paper
• MSC transplantation: a promising therapeutic strategy to manage the onset and progression of diabetic nephropathy.

  2012cites this paper
• Patient Perspectives on Personalized Glucose Advisory Systems for Type 1 Diabetes Management

  2012cites this paper
• How Basal Insulin Analogs Have Changed Diabetes Care

  2011cites this paper
• Analysis of Patient Satisfaction with a Prefilled Insulin Injection Device in Patients with Type 1 and Type 2 Diabetes

  2011cites this paper
• Current world literature.

  2006cites this paper